Unraveling the Mechanisms of Active Saponins from Rhizoma Anemarrhenae Against Ferroptosis in Alzheimer's Disease: Integrating Network Pharmacology, Cell Membrane Chromatography, and Experimental Validation.
Jing Peng, Zhongjiao Lu, Fangfang Sai, Liang Min, Xu Zhang, Dan Ru, Yaying Song, Xin Wei, Li Gao, Hai-Qiao Wang
{"title":"Unraveling the Mechanisms of Active Saponins from <i>Rhizoma Anemarrhenae</i> Against Ferroptosis in Alzheimer's Disease: Integrating Network Pharmacology, Cell Membrane Chromatography, and Experimental Validation.","authors":"Jing Peng, Zhongjiao Lu, Fangfang Sai, Liang Min, Xu Zhang, Dan Ru, Yaying Song, Xin Wei, Li Gao, Hai-Qiao Wang","doi":"10.1142/S0192415X25500429","DOIUrl":null,"url":null,"abstract":"<p><p><i>Rhizoma Anemarrhenae</i>, in which the primary active components are saponins, has shown potential in treating Alzheimer's disease (AD). However, the specific mechanisms of action and the active saponins responsible remain unclear. This study aimed to explore the mechanisms of action and identify the active components of <i>Rhizoma Anemarrhenae</i> saponins (RAS). First, 24 saponin components in RAS and eight absorbed saponins in rats were identified. Then, a component-target interaction network between eight saponins and 83 targets was constructed after target refinement and SPR validation. Bioinformatics analysis indicated that these targets were closely related to lipid metabolism, iron metabolism, and the AMPK signaling pathway. In addition, differentially expressed genes from RAS intervention were significantly enriched in the ferroptosis pathway. <i>In vitro</i> and <i>in vivo</i> assays demonstrated that RAS could inhibit neuronal ferroptosis and alleviate cognitive impairment. Notably, the ferroptosis inducer markedly reversed the neuroprotective effects of RAS. Moreover, silencing AMPK or Nrf2 using the siRNA or AMPK inhibitor abolished the neuroprotective and ferroptosis-inhibitory effects of RAS <i>in vivo</i> or <i>in vitro</i>. Silencing LKB1 reversed the RAS-induced activation of the AMPK/Nrf2 pathway, and co-immunoprecipitation assay revealed that RAS could promote the LKB1-AMPK interaction. Finally, a 2D comprehensive NC/CMC system was used to screen out four potential saponins that inhibit neuronal ferroptosis, with Timosaponin B-III, Timosaponin A-I, and Timosaponin A-III being validated. In conclusion, RAS exerts anti-AD effects by enhancing the LKB1-AMPK interaction, and activating the AMPK/Nrf2 pathway, inhibiting neuronal ferroptosis as a result. Three saponins are identified as the active components potentially responsible for this effect.</p>","PeriodicalId":94221,"journal":{"name":"The American journal of Chinese medicine","volume":"53 4","pages":"1119-1154"},"PeriodicalIF":5.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The American journal of Chinese medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1142/S0192415X25500429","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Rhizoma Anemarrhenae, in which the primary active components are saponins, has shown potential in treating Alzheimer's disease (AD). However, the specific mechanisms of action and the active saponins responsible remain unclear. This study aimed to explore the mechanisms of action and identify the active components of Rhizoma Anemarrhenae saponins (RAS). First, 24 saponin components in RAS and eight absorbed saponins in rats were identified. Then, a component-target interaction network between eight saponins and 83 targets was constructed after target refinement and SPR validation. Bioinformatics analysis indicated that these targets were closely related to lipid metabolism, iron metabolism, and the AMPK signaling pathway. In addition, differentially expressed genes from RAS intervention were significantly enriched in the ferroptosis pathway. In vitro and in vivo assays demonstrated that RAS could inhibit neuronal ferroptosis and alleviate cognitive impairment. Notably, the ferroptosis inducer markedly reversed the neuroprotective effects of RAS. Moreover, silencing AMPK or Nrf2 using the siRNA or AMPK inhibitor abolished the neuroprotective and ferroptosis-inhibitory effects of RAS in vivo or in vitro. Silencing LKB1 reversed the RAS-induced activation of the AMPK/Nrf2 pathway, and co-immunoprecipitation assay revealed that RAS could promote the LKB1-AMPK interaction. Finally, a 2D comprehensive NC/CMC system was used to screen out four potential saponins that inhibit neuronal ferroptosis, with Timosaponin B-III, Timosaponin A-I, and Timosaponin A-III being validated. In conclusion, RAS exerts anti-AD effects by enhancing the LKB1-AMPK interaction, and activating the AMPK/Nrf2 pathway, inhibiting neuronal ferroptosis as a result. Three saponins are identified as the active components potentially responsible for this effect.
以皂苷为主要活性成分的海参在治疗阿尔茨海默病(AD)方面具有一定的潜力。然而,具体的作用机制和活性皂苷仍不清楚。本研究旨在探讨海参皂苷(RAS)的作用机制,并鉴定其有效成分。首先,鉴定出RAS中的24种皂苷成分和大鼠体内吸收的8种皂苷成分。然后,经过目标细化和SPR验证,构建了8种皂苷与83个靶点的组分-靶点相互作用网络。生物信息学分析表明,这些靶点与脂质代谢、铁代谢和AMPK信号通路密切相关。此外,RAS干预的差异表达基因在铁下垂途径中显著富集。体外和体内实验表明,RAS能抑制神经元下垂,减轻认知功能障碍。值得注意的是,铁下垂诱导剂明显逆转RAS的神经保护作用。此外,使用siRNA或AMPK抑制剂沉默AMPK或Nrf2可在体内或体外消除RAS的神经保护作用和凋亡抑制作用。沉默LKB1逆转了RAS诱导的AMPK/Nrf2通路的激活,共同免疫沉淀实验显示RAS可以促进LKB1-AMPK的相互作用。最后,采用2D综合NC/CMC系统筛选出4种抑制神经元铁凋亡的潜在皂苷,对Timosaponin B-III、Timosaponin a - i和Timosaponin a - iii进行验证。综上所述,RAS通过增强LKB1-AMPK相互作用,激活AMPK/Nrf2通路,从而抑制神经元铁下垂,从而发挥抗ad作用。三种皂苷被确定为可能导致这种效果的活性成分。